Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Paul Edward Gross. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Paul Edward Gross har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CLVS / Clovis Oncology Inc See Remarks 98.330
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Paul Edward Gross. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Paul Edward Gross som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.135 98.330 -2,13 0,98 -2.098 96.649
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.595 95.840 -2,64 0,98 -2.551 94.201
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 100.465 4,83
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.623 98.435 6,06
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.308 92.812 -2,43 1,20 -2.770 111.374
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.063 95.120 5,62
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.169 90.057 -2,35 1,46 -3.169 131.582
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.638 87.601 -2,92 1,46 -3.854 127.994
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 92.226 5,28
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.624 90.239 6,65
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.403 84.615 -2,76 0,64 -1.544 54.357
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.062 87.018 6,18
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.062 81.956 -2,45 1,97 -4.062 161.437
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.508 79.393 -3,06 1,97 -4.940 156.388
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 32.375 -12,50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.623 16.872 -25,00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 84.018 5,83
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.623 81.901 7,37
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10.416 76.278 -12,01 1,87 -19.436 142.335
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -290 66.444 -0,43 1,87 -541 123.985
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 563 0 -100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20.250 60.750 50,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20.250 86.694 30,48
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 66.734 0,85
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.453 66.171 -3,57 1,94 -4.758 128.345
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.983 63.999 -4,45 1,94 -5.786 124.132
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 37.000 -11,11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.625 22.495 -20,00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 68.624 7,23
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.625 66.982 9,17
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -248 61.357 -0,40 3,00 -744 184.071
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 563 -49,96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 61.605 0,92
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.041 61.043 -3,24 4,55 -9.287 277.746
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.482 58.459 -4,07 4,55 -11.293 265.988
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 41.625 -10,00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.623 28.120 -16,66
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 63.084 7,91
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.623 60.941 10,16
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 55.318 -0,45 4,89 -1.218 270.505
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 1.125 -33,35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 55.567 1,02
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.034 55.004 -3,57 4,82 -9.804 265.119
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.473 52.413 -4,51 4,82 -11.920 252.631
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 46.250 -9,09
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.624 33.743 -14,29
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 57.038 8,82
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.624 54.886 11,42
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -231 49.262 -0,47 5,63 -1.301 277.345
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 562 1.688 49,91
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 49.493 1,15
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.448 48.931 -2,87 5,54 -8.022 271.078
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.183 47.312 -4,41 5,54 -12.094 262.108
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.207 44.870 -2,62 5,54 -6.687 248.580
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 50.875 -8,33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.623 39.367 -12,50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.067 50.379 6,48
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 49.495 10,31
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.556 46.077 5,87
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 43.521 -0,57 6,29 -1.566 273.747
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -207 43.207 -0,48 6,29 -1.302 271.772
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 563 2.250 33,37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 469 0 -100,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 43.770 1,30
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 43.414 1,09
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9.255 42.945 -17,73 7,97 -73.762 342.272
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.431 33.700 -4,07 7,97 -11.405 268.589
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.187 32.063 -3,57 7,97 -9.460 255.542
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18.500 55.500 -25,00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.625 44.990 -11,11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18.500 52.200 54,90
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.068 35.131 9,57
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.557 33.250 8,33
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 2.813 -16,65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 469 -50,00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 30.693 -0,80 4,89 -1.218 150.089
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 30.942 1,85
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -208 30.380 -0,68 4,89 -1.017 148.558
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 30.588 1,56
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.623 50.615 -10,00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.067 31.501 10,79
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.152 28.434 -3,89 4,93 -5.679 140.180
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.556 29.586 9,46
2020-11-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.382 30.119 -4,39 4,93 -6.813 148.487
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 3.375 -14,30
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 938 -33,33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -237 27.030 -0,87 5,30 -1.256 143.259
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 27.267 2,11
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -198 26.704 -0,74 5,30 -1.049 141.531
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 26.902 1,77
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.624 56.238 -9,09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.367 26.433 -4,92 5,92 -8.093 156.483
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.068 27.800 12,40
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.139 24.732 -4,40 5,92 -6.743 146.413
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.556 25.871 10,96
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 3.938 -12,49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -468 1.407 -24,96
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -256 23.315 -1,09 7,03 -1.800 163.904
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 23.571 2,44
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -214 23.009 -0,92 7,03 -1.504 161.753
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 468 23.223 2,06
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5.623 61.862 -8,33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.207 22.755 -5,04 8,10 -9.777 184.316
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.067 23.962 14,68
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.006 20.895 -4,59 8,10 -8.149 169.250
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.556 21.901 13,21
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 4.500 -11,12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 1.875 -20,01
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -259 19.345 -1,32 7,20 -1.865 139.284
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 19.604 2,96
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -216 19.041 -1,12 7,20 -1.555 137.095
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 19.257 2,50
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -22.497 67.485 -25,00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -5.427 18.788 -22,41 8,41 -45.641 158.007
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 12.271 24.215 102,74
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -5.043 11.944 -29,69 8,41 -42.412 100.449
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 10.226 16.987 151,25
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74.000 74.000
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 5.063 -9,99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 2.344 -16,67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -254 6.500 -3,76 14,59 -3.706 94.835
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 6.754 9,08
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -212 6.192 -3,31 14,59 -3.093 90.341
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 6.404 7,90
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 5.625 -9,10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 2.813 -14,29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -270 5.935 -4,35 5,21 -1.407 30.921
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 6.205 9,98
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -225 5.642 -3,84 5,21 -1.172 29.395
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 5.867 8,69
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 6.188 -8,33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -468 3.282 -12,48
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -247 4.316 -5,41 15,07 -3.722 65.042
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 4.563 14,05
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -206 4.001 -4,90 15,07 -3.104 60.295
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 468 4.207 12,52
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2.250 6.750 -25,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 3.750 -11,12
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.088 3.739 -22,54 29,29 -31.868 109.515
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.250 4.827 87,31
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -237 2.577 -8,42 29,29 -6.942 75.480
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 2.814 20,00
2019-02-04 3 CLVS Clovis Oncology, Inc.
Common Stock
4.690
2019-02-04 3 CLVS Clovis Oncology, Inc.
Common Stock
4.690
2019-02-04 3 CLVS Clovis Oncology, Inc.
Common Stock
4.690
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 89.982 89.982
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 29.994 29.994
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)